Subscribe to RSS
DOI: 10.1055/s-0036-1588409
Synthesis of C-Ribosyl-1,2,3-triazolyl Carboxamides
Publication History
Received: 16 November 2016
Accepted after revision: 13 January 2017
Publication Date:
07 February 2017 (online)
Abstract
Because of the emergence of new viruses, the need for new antiviral broad-spectrum compounds remains important. In this context, herein the synthesis of C-nucleosides, structurally close to ribavirin, a nucleoside presenting various biological activities and used until now particularly for its broad-spectrum antiviral properties, is reported. The compounds were designed in order to increase their stability and the number of hydrogen bond donor or acceptor in comparison to ribavirin, and to investigate the role of the carboxamide group on the biological activity. The efficient synthesis of 11 C-nucleosides is based on an indium-mediated alkynylglycosylation as the key step, followed by the construction of the triazole heterocycle. Amidation was performed with primary and secondary amines in yields up to 85%. An analogue nucleoside with a triazole without carboxamide group was also prepared in order to compare its activity. Finally, the carboxamide group was moved to the N-1 triazole position to mimic ribavirin.
Supporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0036-1588409.
- Supporting Information
-
References
- 1a Gish RG. J. Antimicrob. Chemother. 2006; 57: 8
- 1b Wu JZ, Lin C.-C, Hong Z. J. Antimicrob. Chemother. 2003; 52: 543
- 2 Zeuzem S, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH, Illeperuma A, Svarovskaia E, Brainard DM, Symonds WT, Subramanian GM, McHutchison JG, Weiland O, Reesink HW, Ferenci P, Hézode C, Esteban R. N. Engl. J. Med. 2014; 370: 1993
- 3 Crotty S, Cameron C, Andino R. J. Mol. Med. 2002; 80: 86
- 4 Pankiewicz KW, Felczak K. Heterocycl. Commun. 2015; 21: 249
- 5 Krajczyk A, Kulinska K, Kulinski T, Hurst B, Day CW, Smee DF, Ostrowski T, Januszczyk P, Zeidler J. Antiviral Chem. Chemother. 2014; 23: 161
- 6 De Clerq E. J. Med. Chem. 2016; 59: 2301
- 7 Feng JY, Cheng G, Perry J, Barauskas O, Xu Y, Fenaux M, Eng S, Tirunagari N, Peng B, Yu M, Tian Y, Lee Y-J, Stepan GL, Lagpacan L, Jin D, Hung M, Ku KS, Han B, Kitrinos K, Perron M, Gabriel B, Wong KA, Zhong WC, Kim U, Carey A, Cho A, Ray AS. Antimicrob. Agents Chemother. 2014; 58: 1930
- 8 Julander JG, Bantia S, Taubenheim BR, Minning DM, Kotian PD, Morrey J, Smee DF, Sheridan WP, Babub YS. Antimicrob. Agents Chemother. 2014; 58: 6607
- 9 Lubin-Germain N, Baltaze JP, Coste A, Hallonet A, Lauréano H, Legrave G, Uziel J, Augé J. Org. Lett. 2008; 10: 725
- 10 Schulze B, Schubert US. Chem. Soc. Rev. 2014; 43: 2522
- 11 Ferreira LG, Pinheiro LC. S, Santos-Filho AO, Peçanha MD. S, Sacramento CQ, Machado V, Ferreira VF, Souza TM. L, Boechat N. Med. Chem. Res. 2014; 23: 1501
- 12 Pokhodylo N, Shyyka O, Matiychuk V. Med. Chem. Res. 2014; 23: 2426
- 13 Aït Youcef R, Dos Santos M, Roussel S, Baltaze JP, Lubin-Germain N, Uziel J. J. Org. Chem. 2009; 74: 4318
- 14 Altona C, Sundaralingam M. J. Am. Chem. Soc. 1973; 95: 2333